{"brief_title": "NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes", "brief_summary": "This trial is conducted in the United States of America (USA). The aim of this trial is to assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to insulin lispro, both in insulin pumps, in standard clinical practice.", "condition": ["Diabetes", "Diabetes Mellitus, Type 1", "Diabetes Mellitus, Type 2"], "intervention_type": ["Drug"], "intervention_name": ["insulin aspart"], "criteria": "Inclusion Criteria: - People with Type I or Type II Diabetes - 18 Years or Older.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Diabetes", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Diabetes Mellitus, Type 1", "Insulin, Globin Zinc", "Insulin", "Insulin Aspart"], "id": "NCT00095446"}